During the past decade, Ningbo Kangning Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ningbo Kangning Hospital" #1 collaborator was "Beijing Novartis Pharma" with 1 trials as a collaborator and "Su Zhou YiHua Biotechnology Co. LTD" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Ningbo Kangning Hospital" are "Major Depressive Disorder" (2 trials), "Alzheimer Disease" (1 trials), "Alzheimer's Disease" (1 trials), "Dementia" (1 trials) and "Mild Cognitive Impairment" (1 trials). Many other conditions were trialed in "Ningbo Kangning Hospital" in a lesser frequency.

Most popular intervention types in "Ningbo Kangning Hospital" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Anyu Peibo" (1 trials), "Hypidone Hydrochloride tablets" (1 trials) and "Sodium Oligomannate Capsules" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ningbo Kangning Hospital" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Ningbo Kangning Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Ningbo Kangning Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ningbo Kangning Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".